Vivos Inc.

RDGL ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $36.4K $36.1K $24.8K $1.9K $15.0K $26.7K $-18.0K $5.0K
Cost of Revenue $38.1K $44.1K $27.9K $14.7K $49.8K $35.8K $10.3K $3.9K
Gross Profit $-1.7K $-8.0K $-3.1K $-12.8K $-34.8K $-9.1K $-5.3K $1.1K
Gross Margin -4.7% -22.2% -12.5% -682.0% -231.7% -34.0% 29.4% 21.6%
Operating Expenses
Research & Development $49.2K $37.9K $57.2K $67.8K $108.0K $119.3K $101.0K $66.6K
SG&A Expense $82.3K $58.7K $90.5K $72.9K $80.9K $52.2K $98.4K $65.1K
Operating Income $-654.5K $-545.5K $-1.1M $-531.0K $-674.8K $-863.5K $-661.8K $-843.1K
Operating Margin -1,798.2% -1,512.4% -4,426.8% -28,260.9% -4,498.5% -3,228.4% 3,675.7% -16,862.9%
Interest Expense — — — — — — — —
Pretax Income $-830.2K $-1.2M $-1.1M $-507.3K $-645.5K $-834.7K $-1.0M $-825.3K
Income Tax Expense — — — — — — — —
Net Income $-830.2K $-1.2M $-1.1M $-507.3K $-645.5K $-834.7K $-1.0M $-825.3K
Net Margin -2,280.7% -3,285.0% -4,357.3% -26,998.1% -4,303.4% -3,120.6% 5,682.8% -16,505.3%
EPS (Basic) $0.00 $0.00 $-0.01 $0.00 $0.00 $0.00 $-0.01 $0.00
EPS (Diluted) $0.00 $0.00 $-0.01 $0.00 $0.00 $0.00 $-0.01 $0.00
Shares Outstanding (Basic) 490.7M 462.2M 452.7M 454.3M 453.5M 448.2M 409.7M 418.6M
Shares Outstanding (Diluted) 490.7M 462.2M 452.7M 454.3M 453.5M 448.2M 409.7M 418.6M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 5 Older →